Your Location:
Home >
Browse articles >
Mechanism of Modified Erchentang on COPD Inflammation Based on TNF-α /TNFR1/RIPKs Pathway
Mechanism of Modified Erchentang on COPD Inflammation Based on TNF-
α /TNFR1/RIPKs Pathway- “The latest research has found that modified Erchen Tang can effectively improve the inflammatory response of lung tissue in rats with chronic obstructive pulmonary disease, and its mechanism may be through inhibiting the TNF - α/TNFR1/RIPKs signaling pathway.”
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 30, Issue 9, Pages: 40-47(2024)
DOI: 10.13422/j.cnki.syfjx.20240304
Scan QR Code
AI Introduction
Full Text(HTML)
Figs( 1 ) Tabs( 5 )
References
Publication Info
Metrics
398
Views
188
Downloads
6
CSCD
Alert me when the article has been cited
Submit
Tools
- BibTeXDownload
- EndnoteDownload
- RefMan Download
- NoteExpressDownload
- NoteFirstDownload
Related Articles
Effect of Modified Erchentang on Expressions of Chemokine Receptor CXCR1/2 and CXCL8 in Patients with AECOPD
Effect of Modified Erchentang on GATA3 and T-bet mRNA Expressions in Lung Tissue of Chronic Obstructive Pulmonary Disease Rats
Research Progress of Chronic Obstructive Pulmonary Disease in Mechanism and Treatment of Traditional Chinese Medicine
Clinical Observation on Treatment of Stable Chronic Obstructive Pulmonary Disease with Yanghe Dingchuan Prescription Combined with Budesonide and Formoterol Inhalation
Exploring Multi-target Synergistic Mechanisms of Compound Yiqi Weixue Prescription with Medicinal and Edible Value in Alleviating Premenstrual Syndrome Based on Transcriptomics
Related Author
Li-zhi SHANG
Shu JI
Yao-yang LI
Meng-di MAO
Guo-qiang WANG
Long-tao SHI
Guang-yuan ZHANG
Li-li XU
Related Institution
Jingan Hospital of Traditional Chinese Medicine
Xiaodongmen Community Health Service Center, Huangpu District
Jing'an District Central Hospital, Fudan University
School of Pharmacy, Anhui University of Chinese Medicine
Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences


